Abstract
Allergic rhinitis (AR) is characterized by an early-phase response (EPR), and in a subgroup of individuals, a late-phase response (LPR). We sought to investigate polymorphisms in cholinergic synapse pathway genes, previously associated with late-asthmatic responses, in the LPR. Twenty healthy participants and 74 participants with AR underwent allergen exposure using the Environmental Exposure Unit. Allergic participants were sub-phenotyped using self-reported nasal congestion scores; congestion is the predominant symptom experienced during the LPR. Acute congestion (AC, n = 36) participants developed only an EPR, while persistent congestion (PC, n = 38) participants developed both allergic responses. We interrogated blood samples collected before allergen exposure with genotyping and gene expression assays. Twenty-five SNPs located in ADCY3, AKT3, CACNA1S, CHRM3, CHRNB2, GNG4, and KCNQ4 had significantly different allele frequencies (P < 0.10) between PC and AC participants. PC participants had increased minor allele content (P = 0.009) in the 25 SNPs compared to AC participants. Two SNPs in AKT3 were associated with gene expression differences (FDR < 0.01) in PC participants. This study identified an association between the LPR and polymorphisms in the cholinergic synapse pathway genes, and developed a novel method to sub-phenotype AR using self-reported nasal congestion scores.
Highlights
Allergic rhinitis (AR) is the most prevalent clinical manifestation of allergy, affecting up to 40% of the global population [1]
We studied nasal congestion during and after allergen exposure in a controlled setting, using the Environmental Exposure Unit (EEU), and developed a protocol to sub-phenotype AR
We identified an association between the late-phase response (LPR) and polymorphisms in cholinergic synapse pathway genes (ADCY3, AKT3, CACNA1S, CHRM3, CHRNB2, GNG4, and KCNQ4)
Summary
Allergic rhinitis (AR) is the most prevalent clinical manifestation of allergy, affecting up to 40% of the global population [1]. Significant economic and quality of life impacts are associated with AR including decreased productivity, cognitive function, and sleep [2, 3]. AR is a heterogeneous disorder defined by IgE-mediated inflammation of the nasal mucosa. Allergic responses are initiated by environmental allergen exposure in genetically predisposed individuals, resulting in symptoms of rhinorrhea, sneezing, nasal congestion, and exacerbation of comorbid asthma [4]. Children and adults with AR have an increased risk of developing allergic asthma [5, 6].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.